Digital health technologies (DHT) offer the ability to deliver personalized care, lower barriers to access, and positively impact health outcomes. However, DHT utilization is impacted by insufficient market access pathways. A policy “full-stack”—including regulatory authorization, product value assessment, pricing and reimbursement, and patient access infrastructure—offers a framework for DHT integration into national healthcare ecosystems. Consistent clinical evidence requirements across national jurisdictions will further increase DHT scalability.

中文翻译：

---

数字医疗技术证据和获取国家政策的核心要素


数字健康技术 (DHT) 能够提供个性化护理、降低获取障碍并对健康结果产生积极影响。然而，DHT 的利用受到市场准入途径不足的影响。政策“全栈”——包括监管授权、产品价值评估、定价和报销以及患者访问基础设施——为 DHT 融入国家医疗保健生态系统提供了框架。各国司法管辖区一致的临床证据要求将进一步提高 DHT 的可扩展性。